The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ADVERUM BIOTECHNOLOGIES INC | COM | 00773U108 | 1,740 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 29,831 | 364,776 | SH | SOLE | 364,776 | 0 | 0 | ||
| ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 29,775 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| AUDENTES THERAPEUTICS INC | COM | 05070R104 | 13,523 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
| BEIGENE LTD | SPONSORED ADR | 07725L102 | 11,760 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
| BLUEBIRD BIO INC | COM | 09609G100 | 24,759 | 145,000 | SH | SOLE | 145,000 | 0 | 0 | ||
| BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 31,912 | 348,000 | SH | SOLE | 348,000 | 0 | 0 | ||
| CELGENE CORP | COM | 151020104 | 3,568 | 40,000 | SH | Call | SOLE | 40,000 | 0 | 0 | |
| CLOVIS ONCOLOGY INC | COM | 189464100 | 9,372 | 177,500 | SH | SOLE | 177,500 | 0 | 0 | ||
| CODEXIS INC | COM | 192005106 | 22,275 | 2,025,000 | SH | SOLE | 2,025,000 | 0 | 0 | ||
| CRISPR THERAPEUTICS AG | NAMEN AKT | H17182108 | 6,171 | 135,000 | SH | SOLE | 135,000 | 0 | 0 | ||
| CYTOMX THERAPEUTICS INC | COM | 23284F105 | 5,903 | 207,500 | SH | SOLE | 207,500 | 0 | 0 | ||
| EDITAS MEDICINE INC | COM | 28106W103 | 4,420 | 133,333 | SH | SOLE | 133,333 | 0 | 0 | ||
| EVOLENT HEALTH INC | CL A | 30050B101 | 15,818 | 1,110,000 | SH | SOLE | 1,110,000 | 0 | 0 | ||
| FATE THERAPEUTICS INC | COM | 31189P102 | 25,376 | 2,600,000 | SH | SOLE | 2,600,000 | 0 | 0 | ||
| FOUNDATION MEDICINE INC | COM | 350465100 | 40,950 | 520,000 | SH | SOLE | 520,000 | 0 | 0 | ||
| GENMARK DIAGNOSTICS INC | COM | 372309104 | 20,944 | 3,850,000 | SH | SOLE | 3,850,000 | 0 | 0 | ||
| GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 28,980 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
| HOMOLOGY MEDICINES INC | COM | 438083107 | 1,122 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
| ILLUMINA INC | COM | 452327109 | 16,904 | 71,500 | SH | SOLE | 71,500 | 0 | 0 | ||
| ISHARES TR | NASDAQ BIOTECH | 464287556 | 10,140 | 95,000 | SH | SOLE | 95,000 | 0 | 0 | ||
| JOUNCE THERAPEUTICS INC | COM | 481116101 | 14,192 | 635,000 | SH | SOLE | 635,000 | 0 | 0 | ||
| LOXO ONCOLOGY INC | COM | 548862101 | 41,533 | 360,000 | SH | SOLE | 360,000 | 0 | 0 | ||
| MYOKARDIA INC | COM | 62857M105 | 27,328 | 560,000 | SH | SOLE | 560,000 | 0 | 0 | ||
| NEOGEN CORP | COM | 640491106 | 4,354 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
| ORASURE TECHNOLOGIES INC | COM | 68554V108 | 4,054 | 240,000 | SH | SOLE | 240,000 | 0 | 0 | ||
| SAGE THERAPEUTICS INC | COM | 78667J108 | 40,268 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| SANGAMO THERAPEUTICS INC | COM | 800677106 | 26,600 | 1,400,000 | SH | SOLE | 1,400,000 | 0 | 0 | ||
| SPARK THERAPEUTICS INC | COM | 84652J103 | 30,831 | 463,000 | SH | SOLE | 463,000 | 0 | 0 | ||
| VOYAGER THERAPEUTICS INC | COM | 92915B106 | 21,327 | 1,135,000 | SH | SOLE | 1,135,000 | 0 | 0 | ||
| ZAI LAB LTD | ADR | 98887Q104 | 2,882 | 135,000 | SH | SOLE | 135,000 | 0 | 0 | ||